Stryker Corporation (SYK)

SYK (NYSE:Health Services)
pos +0.19
Today's Range: 80.09 - 80.79 | SYK Avg Daily Volume: 1,435,400
Last Update: 07/30/14 - 4:04 PM EDT
Volume: 1,229,938
YTD Performance: 6.76%
Open: $80.41
Previous Close: $80.22
52 Week Range: $66.44 - $86.93
Oustanding Shares: 378,582,992
Market Cap: 30,320,711,829
6-Month Chart
TheStreet Ratings Grade for SYK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 13 12 12
Moderate Buy 1 1 1 1
Hold 9 9 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.84 1.80 1.89 1.89
Latest Dividend: 0.30
Latest Dividend Yield: 1.52%
Dividend Ex-Date: 09/26/14
Price Earnings Ratio: 44.74
Price Earnings Comparisons:
SYK Sector Avg. S&P 500
44.74 44.60 28.94
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
2.98% 14.03% 47.63%
Revenue 4.20 0.23 0.07
Net Income -22.50 -0.21 -0.07
EPS -22.30 -0.17 -0.06
Earnings for SYK:
Revenue 9.02B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.14 $1.49 $4.77 $5.30
Number of Analysts 14 14 19 20
High Estimate $1.16 $1.51 $4.80 $5.36
Low Estimate $1.13 $1.45 $4.73 $5.20
Prior Year $0.98 $1.23 $4.23 $4.77
Growth Rate (Year over Year) 16.25% 20.85% 12.70% 11.08%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

This Morning's Market Setup Real Money Pro($)

Where it began.
Jun 11, 2014 | 8:17 AM EDT
SYK was upgraded from Hold to Buy, Argus Research said. $102 price target. Company is generating solid growth outside of orthopedics.&n...

Time to Load Up on Hologic Real Money Pro($)

Positive developments and an attractive entry point make the stock a table-pounding buy.
Feb 18, 2014 | 8:34 AM EST
Shares of SYK now seen reaching $86, according to Goldman Sachs. Estimates also increased, given better working capital use and higher ...
Feb 13, 2014 | 7:31 AM EST
Leerink Swann Global Healthcare Conference (Day 2 of 2) - 02/12/14 - 02/13/14 New York, NY
They should improve shareholder value in coming months.
The medical technology firm's acquisitions are starting to pay off. 

Earnings Push Into the Black Real Money Pro($)

Earnings reactions are lifting the entire market. 
Sep 06, 2013 | 8:25 AM EDT
SYK was upgraded from Neutral to Outperform, Credit Suisse said. $77 price target. Valuation call, as the stock has pulled back 14% and...
Jul 19, 2013 | 7:06 AM EDT
SYK was downgraded from Buy to Hold, Wunderlich said. $71 price target. Company lacks near-term catalysts. 

Columnist Conversations

Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market gets hit from impact of sanctions against Russia for second day in row but manages to rally a bit to en...
We took out some of the high end of support, but I'm still looking at this symmetrical pullback for entries on...
going into trading today roughly 37 million shares of X (US Steel) was held big X has traded 27 mi...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.